SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anaxagoras who wrote (1727)1/15/1998 12:59:00 PM
From: Linda Kaplan  Read Replies (2) of 7041
 
Anaxagoras,

I did indeed notice that Asensio's release didn't stop the uptrend today. I assume someone is buying (other than you -- hehe).

I don't know how much work SGP did. I was watching a company recently which had a deal with a big company to market their drug when it was approved and that big company bowed out. It was quite a surprise to the stockholders who had bought in part on the basis of that larger pharmaceutical company's good name. I'd sold my own shares earlier when the promise didn't seem to be panning out, so I wasn't personally effected by that announcement, but I was certainly impressed by it. I can conclude from this superficial view that sometimes these larger companies make a mistake. Which is not to say that I'm taking a position that SGP made a mistake with ZONA, of course. I have no information at all. Insert large disclaimer here, please.

What's the big picture, here, though? Does ZONA have any viable technology, and can it become profitable, and if so, when?

Let me know about the new short, if and when you can?

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext